Fuertes, Charlene .
HRN: 24-21-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/09/2024
AMPICILLIN 1GM (VIAL)
01/09/2024
01/11/2024
IV
2g
Q6
Prom
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes